Science
Mechanism of Action
It modulates melanogenesis by interfering with the glycosylation process of tyrosinase and tyrosinase-related protein 1 (TRP1), rather than simply inhibiting enzyme activity. By altering how these enzymes are matured and transported within the cell, it effectively reduces the synthesis of melanin at a structural level.
Research
Clinical Evidence
High confidence5%
Key findings
- 01 Clinical trials on 50 subjects with chloasma demonstrated significant visible reduction in hyperpigmentation using a 10% topical concentration.
- 02 Research indicates that when combined with hydroxyapatite, it significantly enhances skin barrier resilience and baseline hydration levels.
Transparency
Dusting Analysis
Due to its high cost and technical profile, it is frequently used at 'claim levels' (under 0.5%) by mass-market brands. Clinical efficacy for pigment correction typically requires concentrations of 1% or higher.
The Formula
Formulation
Stability
Highly stable in aqueous solutions at room temperature; however, it is thermolabile and should not be exposed to temperatures exceeding 40°C during formulation.
Synergies
- Hydroxyapatite
- Niacinamide
- Vitamin C derivatives
Conflicts
- Strong mineral acids
- Strong alkalines
- Potent oxidizing agents
Safety
Safety Profile
Extensive use by luxury global dermatological brands confirms its safety profile; 48-hour patch testing on compromised skin showed zero irritation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A highly effective, non-irritating alternative to traditional lighteners that excels in correcting pigment disorders while strengthening the skin barrier.
Related
Similar Ingredients
Finding similar ingredients…